Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Filhol

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Scientific Reports|November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitorsIrina Kufareva, Benoit Bestgen, Paul Brear, et al.
Cancers|July 2, 2021
NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive MicroenvironmentDeborah Reynaud, Roland Abi Nahed, Nicolas Lemaitre, et al.
Nanomaterials (Basel, Switzerland)|December 8, 2023
Intracellular Fate of Sub-Toxic Concentration of Functionalized Selenium Nanoparticles in Aggressive Prostate Cancer CellsCaroline Bissardon, Olivier Proux, Salvatore Andrea Gazze, et al.
Iscience|February 6, 2024
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocketAlexandre Bancet, Rita Frem, Florian Jeanneret, et al.
Nature|May 23, 2008
A phosphatase cascade by which rewarding stimuli control nucleosomal responseAlexandre Stipanovich, Emmanuel Valjent, Miriam Matamales, et al.
Cell Reports|March 16, 2022
Extracellular endosulfatase Sulf-2 harbors a chondroitin/dermatan sulfate chain that modulates its enzyme activityRana El Masri, Amal Seffouh, Caroline Roelants, et al.
British Journal of Cancer|March 23, 2018
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinomaHelena Polena, Julie Creuzet, Maeva Dufies, et al.
Cancers|February 5, 2021
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS OverproductionSofia Giacosa, Catherine Pillet, Irinka Séraudie, et al.
Nature Communications|May 10, 2020
A RUNX2 stabilization pathway mediates physiologic and pathologic bone formationJung-Min Kim, Yeon-Suk Yang, Kwang Hwan Park, et al.
Cancer Research|July 5, 2012
Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growthRenaud Prudent, Emilie Vassal-Stermann, Chi-Hung Nguyen, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Scientific Reports|November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitorsIrina Kufareva, Benoit Bestgen, Paul Brear, et al.
Cancers|July 2, 2021
NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive MicroenvironmentDeborah Reynaud, Roland Abi Nahed, Nicolas Lemaitre, et al.
Nanomaterials (Basel, Switzerland)|December 8, 2023
Intracellular Fate of Sub-Toxic Concentration of Functionalized Selenium Nanoparticles in Aggressive Prostate Cancer CellsCaroline Bissardon, Olivier Proux, Salvatore Andrea Gazze, et al.
Iscience|February 6, 2024
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocketAlexandre Bancet, Rita Frem, Florian Jeanneret, et al.
Nature|May 23, 2008
A phosphatase cascade by which rewarding stimuli control nucleosomal responseAlexandre Stipanovich, Emmanuel Valjent, Miriam Matamales, et al.
Cell Reports|March 16, 2022
Extracellular endosulfatase Sulf-2 harbors a chondroitin/dermatan sulfate chain that modulates its enzyme activityRana El Masri, Amal Seffouh, Caroline Roelants, et al.
British Journal of Cancer|March 23, 2018
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinomaHelena Polena, Julie Creuzet, Maeva Dufies, et al.
Cancers|February 5, 2021
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS OverproductionSofia Giacosa, Catherine Pillet, Irinka Séraudie, et al.
Nature Communications|May 10, 2020
A RUNX2 stabilization pathway mediates physiologic and pathologic bone formationJung-Min Kim, Yeon-Suk Yang, Kwang Hwan Park, et al.
Cancer Research|July 5, 2012
Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growthRenaud Prudent, Emilie Vassal-Stermann, Chi-Hung Nguyen, et al.
Pageof 7